SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107,839 | -61.3% | 5,240 | -11.5% | 0.06% | -60.6% |
| Q2 2023 | $278,358 | -11.0% | 5,920 | -20.6% | 0.16% | -4.1% |
| Q1 2023 | $312,728 | +12.0% | 7,453 | +1.8% | 0.17% | +17.8% |
| Q4 2022 | $279,185 | -3.4% | 7,320 | -0.9% | 0.15% | +27.0% |
| Q3 2022 | $289,000 | +23.0% | 7,388 | +1.5% | 0.12% | +32.2% |
| Q2 2022 | $235,000 | -26.1% | 7,281 | -24.1% | 0.09% | -38.7% |
| Q1 2022 | $318,000 | -22.1% | 9,594 | 0.0% | 0.14% | -7.8% |
| Q4 2021 | $408,000 | +46.8% | 9,594 | +52.8% | 0.15% | +26.2% |
| Q3 2021 | $278,000 | -28.5% | 6,280 | -8.4% | 0.12% | -23.8% |
| Q2 2021 | $389,000 | -41.3% | 6,853 | -22.6% | 0.16% | -42.9% |
| Q1 2021 | $663,000 | -11.0% | 8,852 | +2.8% | 0.28% | -9.4% |
| Q4 2020 | $745,000 | -24.5% | 8,611 | -46.7% | 0.31% | -40.3% |
| Q3 2020 | $987,000 | +60.5% | 16,142 | +9.2% | 0.52% | +78.0% |
| Q2 2020 | $615,000 | +165.1% | 14,782 | +83.1% | 0.29% | +206.3% |
| Q1 2020 | $232,000 | -63.3% | 8,072 | -7.8% | 0.10% | -7.8% |
| Q4 2019 | $632,000 | +13.1% | 8,753 | +119.7% | 0.10% | -8.8% |
| Q3 2019 | $559,000 | -34.2% | 3,984 | -14.2% | 0.11% | -36.9% |
| Q2 2019 | $850,000 | +101.9% | 4,645 | +75.6% | 0.18% | -80.0% |
| Q1 2019 | $421,000 | +49.3% | 2,645 | -10.3% | 0.90% | +1766.7% |
| Q4 2018 | $282,000 | -30.5% | 2,948 | +2.7% | 0.05% | +14.3% |
| Q3 2018 | $406,000 | -47.3% | 2,871 | -41.7% | 0.04% | -93.8% |
| Q2 2018 | $771,000 | +0.4% | 4,923 | +3.2% | 0.68% | +2.4% |
| Q1 2018 | $768,000 | +113.3% | 4,771 | +118.2% | 0.67% | +47.3% |
| Q4 2017 | $360,000 | +36.4% | 2,187 | -48.3% | 0.45% | +1155.6% |
| Q3 2017 | $264,000 | -13.7% | 4,234 | +10.1% | 0.04% | -21.7% |
| Q2 2017 | $306,000 | -26.3% | 3,846 | -34.1% | 0.05% | -37.8% |
| Q1 2017 | $415,000 | +54.3% | 5,837 | +10.6% | 0.07% | -7.5% |
| Q4 2016 | $269,000 | -33.4% | 5,277 | -39.9% | 0.08% | -59.0% |
| Q3 2016 | $404,000 | +53.0% | 8,774 | 0.0% | 0.20% | -0.5% |
| Q2 2016 | $264,000 | +78.4% | 8,774 | +90.7% | 0.20% | -3.9% |
| Q1 2016 | $148,000 | – | 4,602 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 409,000 | $17,399,000 | 4.82% |
| Palo Alto Investors LP | 781,730 | $33,255,000 | 2.12% |
| DAFNA Capital Management LLC | 180,306 | $7,670,000 | 1.93% |
| Boxer Capital, LLC | 1,094,000 | $46,539,000 | 1.81% |
| Deep Track Capital, LP | 500,000 | $21,270,000 | 1.50% |
| Bellevue Group AG | 3,228,004 | $137,319,000 | 1.42% |
| EcoR1 Capital, LLC | 940,636 | $40,015,000 | 1.28% |
| Deep Track Capital, LP | 400,000 | $17,016,000 | 1.20% |
| Artal Group S.A. | 1,000,000 | $42,540,000 | 1.15% |
| SECTOR GAMMA AS | 98,904 | $4,207,000 | 0.99% |